Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2008
10/29/2008EP1984357A2 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
10/29/2008EP1984356A1 An improved process for the preparation of candesartan cilexetil
10/29/2008EP1984355A2 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension
10/29/2008EP1984353A1 Aurora kinase modulators and method of use
10/29/2008EP1984351A1 Compounds having 5-ht6 receptor affinity
10/29/2008EP1984340A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives
10/29/2008EP1984332A2 Methods for treating hepatitis c
10/29/2008EP1984331A1 Pyrrolidine derivatives as erk inhibitors
10/29/2008EP1984330A1 Chemical compounds
10/29/2008EP1983981A1 Indazole derivatives for treatment of alzheimer's disease
10/29/2008EP1727798B1 Novel aryl-containing 5-acylindolinones, the production thereof and their use as medicaments
10/29/2008EP1531811B1 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
10/29/2008EP1216228B1 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
10/29/2008CN101296924A Pyrazole-isoquinoline urea derivatives as P38 kinase inhibitors
10/29/2008CN101296923A Procedure of preparation of candesartan cilexetil
10/29/2008CN101296920A Functionally selective alpha2C adrenoreceptor agonists
10/29/2008CN101296914A Derivative having PPAR agonistic activity
10/29/2008CN101296911A Arylurea derivatives as modulators of chemokine receptor activity
10/29/2008CN101296910A Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
10/29/2008CN101296909A Pyrazine derivatives and use as pI3K inhibitors
10/29/2008CN101296907A Diaminopyrimidines as P2X3 and P2X2/3 modulators
10/29/2008CN101296903A Novel indole-containing beta agonists, method for producing them and their use as drugs
10/29/2008CN100429201C Heterocyclic compounds and methods of use thereof
10/28/2008USRE40558 Peroxisome proliferator-activated receptors agonists/ antagonists; 2-methyl-6-[3-(quinolin-2-ylmethoxy)-propoxymethyl]-benzoic acid; eating diorders; physiological detrimental blood level of insulin, glucose, free fatty acids, or triglycerides; hyperlipemia; atherosclerosis; antidiabetic agent
10/28/2008US7442805 Substituted sulfonamide-indoles
10/28/2008US7442797 Platinum complex and light emitting device
10/28/2008US7442791 Aminoalkylamide substituted cyclohexyl derivatives
10/28/2008US7442704 Amide derivatives
10/28/2008US7442702 Prostaglandin agonists
10/28/2008US7442701 Amino-heterocycles as VR-1 antagonists for treating pain
10/28/2008US7442700 N-[4-({4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1f][1,2,4]triazin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide; serine/threonine Aurora kinase inhibitor; anticarcinogenic agent; allergies and asthma, Alzheimer's disease, rheumatoid arthritis, autoimmune diseases, bone diseases, inflammation
10/28/2008US7442699 For treatment of rheumatoid arthritis, inflammatory or autoimmune condition, viral infection, cancer; 4-{[4-(4-chlorophenyl)pyrimidin-2-yl]amino}benzamide
10/28/2008US7442698 Substituted heterocyclic compounds and methods of use
10/28/2008US7442697 4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity
10/28/2008US7442693 Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
10/28/2008US7442142 Automatic transmission
10/28/2008CA2442227C Ccr5 antagonists useful for treating aids
10/28/2008CA2423286C Amorphous form of cell cycle inhibitor
10/28/2008CA2350968C Pyrimidinylbenzimidazole and triazinylbenzimidazole derivatives and agricultural/horticultural fungicide
10/28/2008CA2342102C Tan-1057 derivatives
10/23/2008WO2008128009A2 Aminopyrimidines useful as kinase inhibitors
10/23/2008WO2008127728A1 Biaryl compositions and methods for modulating a kinase cascade
10/23/2008WO2008127139A1 Indicyanine dyes and the derivatives thereof for analysing biological micromolecules
10/23/2008WO2008126901A1 Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same
10/23/2008WO2008126899A1 5-membered heterocyclic derivative and use thereof for medical purposes
10/23/2008WO2008125839A2 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase
10/23/2008WO2008125833A1 Pharmaceutical compounds
10/23/2008WO2008125691A2 Ethers of naphtalene carboxylic acid amides as cancer cure
10/23/2008WO2008125627A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
10/23/2008WO2008107398A3 Pyrazine compounds
10/23/2008WO2008100463B1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
10/23/2008WO2008099210A3 Piperazine derivatives for treatment of ad and related conditions
10/23/2008WO2008090357A3 N, n; -substituted piperazines binding to melanocortin receptor
10/23/2008WO2008053341A3 Bridged bicyclic indazoles as cannabinoid receptor ligands
10/23/2008WO2008040995A8 Indazoles for use as dpp-iv inhibitors
10/23/2008US20080262243 Reacting a vinyl sulfone compound with imide compound in presence of catalyst
10/23/2008US20080262045 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12
10/23/2008US20080262041 Beta-Lactams for Treatment of Cns Disorders
10/23/2008US20080262015 therapeutically active 2,4,5-trisubstituted imidazole compounds; alone or in combination; high antineoplastic activity, low systemic toxicity and low mutagenicity on normal cells; inhibitors of p38 MAP kinase; modulators of multi-drug resistance in cancer cells
10/23/2008US20080262005 Uracil-Type Gonadotropin-Releasing Hormone Receptor Antagonists and Methods Related Thereto
10/23/2008US20080261997 Use of aminoindazole derivatives for the inhibition of tau phosphorylation
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261992 Pyridin-2-One Compounds and Their Use as Modulators of the Dopamine D3 Receptor
10/23/2008US20080261987 Substituted piperazines
10/23/2008US20080261978 treating or preventing HIV infections, and in treating proliferative disorders such as inhibiting the metastasis of various cancers; 1-(4-((pyridin-2-ylmethylamino)methyl)benzyl)-3-phenylurea
10/23/2008US20080261951 Condensed azepines as vasopressin agonists
10/23/2008US20080261947 Poly(ADP-ribose)polymerase inhibitor; ischemic diseases, cerebral infarction, antiretroviral, sensitizer for anticancer therapy, immunosuppressant; 5,6,7,8-tetrahydrophthalazin-1(2H)-one compounds; 2,3,4,6-tetrahydropyrido[2,3-d]pyridazin-5(1H)-one compounds
10/23/2008US20080261944 Indole Derivatives as Antiviral Agents
10/23/2008US20080261940 N-(1-Arylpyrazol-4L) Sulfonamides and their Use as Parasiticides
10/23/2008US20080261917 Prodrug; novel series of compounds which inhibit the MDM2-p53 interaction and have in vitro activity exerting an anti-tumour effect; cancer
10/23/2008US20080260829 Bone morphogenic proteins (bmp); cell adhesion modulating agent; peptidomimetics of cyclic peptides comprising classical cadherin cell adhesion recognition (CAR) sequences; modulate cell adhesion and improve drug delivery
10/23/2008US20080260754 Prevent transplant rejection; autoimmune diseases
10/23/2008US20080260685 Prodrugs of cc-1065 analogs
10/23/2008CA2683785A1 Aminopyrimidines useful as kinase inhibitors
10/23/2008CA2683624A1 Pharmaceutical compounds
10/23/2008CA2683619A1 Pharmaceutical compounds
10/23/2008CA2683049A1 Organic compounds
10/23/2008CA2682393A1 5-membered heterocyclic derivative and use thereof for medical purposes
10/23/2008CA2681311A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
10/22/2008EP1982983A1 Improved process for producing moxonidine
10/22/2008EP1981877A1 N-hydroxyacrylamide compounds
10/22/2008EP1981876A1 Triazoloanilinopyrimidine derivatives for use as antiviral agents
10/22/2008EP1981856A2 Pyrimidine derivatives
10/22/2008EP1981855A2 Substituted bis-amide metalloprotease inhibitors
10/22/2008EP1981854A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
10/22/2008EP1981845A2 Sulfonamide derivatives to treat infection with hepatitis c virus
10/22/2008EP1981342A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
10/22/2008EP1756089B1 Mercaptoimidazoles as ccr2 receptor antagonists
10/22/2008EP1658269B1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
10/22/2008EP1654228B1 Tetrahydrocarbazole derivatives and their pharmaceutical use
10/22/2008EP1603562A4 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
10/22/2008EP1458394B1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3
10/22/2008EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor
10/22/2008EP1318983B1 Substituted imidazoles as histamine h1 and h3 agonists or antagonists
10/22/2008CN101291928A 4-heteroarylmethyl substituted phthalazinone derivatives
10/22/2008CN101291927A Benzimidazoles useful as inhibitors of protein kinases
10/22/2008CN101291923A Pyrazolone derivatives for the treatment of tuberculosis
10/22/2008CN101291918A Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
10/22/2008CN101291917A Diaryl urea derivatives in the treatment of protein kinase dependent diseases
10/22/2008CN101291914A Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases
1 ... 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 ... 626